Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Takeda, Abingworth Infuse $100 Million Into a Tiny Biotech, Sealing an Option for M&A May 8, 2017 <b>Teresa L. Kline</b> Joins Intersect ENT???s Board Of Directors July 20, 2017 Puma Biotech Surges After the FDA Officially Approves Breast Cancer Drug July 17, 2017
